SCHEMBL8372008

SCHEMBL8372008

O=C(NCCCO)OCCCO

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.67
TDP1 Q9NUW8 1/20 0.46
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28370366 0.93 ACHE (0.70) ACHETDP1
SCHEMBL11848496 0.91 ACHE (0.61) ACHETDP1CHRNB2CHRNB4CHRNA3
SCHEMBL15686517 0.91 ACHE (0.74) ACHETDP1CHRNB2CHRNB4CHRNA3
SCHEMBL30603265 0.89 ACHE (0.76) ACHETDP1
SCHEMBL2870052 0.88 ACHE (0.80) ACHE
SCHEMBL5248874 0.88 ACHE (0.86) ACHE
SCHEMBL21341289 0.87 ACHE (0.79) ACHETDP1
SCHEMBL12179746 0.86 ACHE (0.62) ACHETDP1CHRNB2CHRNB4CHRNA3
SCHEMBL12990983 0.86 ACHE (0.57) ACHETDP1
SCHEMBL10717902 0.85 ACHE (0.71) ACHECHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3238738-B1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ARBUTUS BIOPHARMA CORP (CA) 2020-09-23 EP disclosed
EP-2355851-B1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ARBUTUS BIOPHARMA CORP (CA) 2018-04-04 EP disclosed
EP-3238738-A1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS Arbutus Biopharma Corporation (CA) 2017-11-01 EP disclosed
WO-2010144740-A1 IMPROVED LIPID FORMULATION ALNYLAM PHARMACEUTICALS, INC. (US) 2010-12-16 WO disclosed
WO-2010105209-A1 LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES ALNYLAM PHARMACEUTICALS, INC. (US) 2010-09-16 WO disclosed
WO-2010054401-A1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ALNYLAM PHARMACEUTICALS, INC. (US) 2010-05-14 WO disclosed
WO-2010054405-A1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ALNYLAM PHARMACEUTICALS, INC. (US) 2010-05-14 WO disclosed
WO-2010054384-A1 LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ALNYLAM PHARMACEUTICALS, INC. (US) 2010-05-14 WO disclosed
WO-2010042877-A1 IMPROVED AMINO LIPIDS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS TEKMIRA PHARMACEUTICALS CORPORATION (CA) 2010-04-15 WO disclosed
EP-0797611-B1 ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT KING INDUSTRIES INC (US) 1999-01-27 EP disclosed
EP-0797611-A1 ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT Blank, Werner J. (US) 1997-10-01 EP disclosed
US-5565531-A AUTOMOBILE PROTECTIVE TOPCOATINGS COMPRISING POLYURETHANES HAVING PENDANT ALKYL CHAINS CONTAINING AN ETHER MADE FROM A DICARBAMATE, POLYOL AND ETHER-CONTAINING CARBAMATE; WEATHERPROOFING; DURABILITY; SOLVENT SOLUBILITY KING INDUSTRIES, INC. (US) 1996-10-15 US disclosed
WO-1995032999-A1 ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT BLANK WERNER J (US) 1995-12-07 WO disclosed